Commure Inc. to Acquire Augmedix Inc. for $139 Million in Equity Value

Commure Inc., a leading provider of technology services to healthcare systems, has made a significant move in the industry by entering into an agreement to acquire Augmedix Inc., an ambient AI medical documentation and data solutions company, for approximately $139 million in equity value.

Under the terms of the deal, Augmedix stockholders will receive $2.35 per share in cash once the transaction is finalized, making Augmedix a wholly owned subsidiary of Commure. This acquisition comes as Commure continues to expand its suite of solutions, which now includes Patient Engagement, Workflow Automation, Staff Safety, At-Home Patient Monitoring, Billing Solutions, and Automated Dictation, following its merger with Athelas.

Manny Krakaris, Chief Executive Officer at Augmedix, expressed excitement about the acquisition, stating, “This proposed transaction with Commure provides certainty and a premium value for our stockholders, representing a transformative next step in Augmedix’s mission to unburden clinicians of administrative tasks while dramatically improving health system efficiency.” He also highlighted the alignment between Augmedix’s mission and vision for the future and Commure’s capabilities to scale ambient documentation solutions and accelerate innovation in the healthcare industry.

Tanay Tandon, Chief Executive Officer at Commure, emphasized the strategic importance of the acquisition, stating, “Through our acquisition of Augmedix, we’re taking a huge step forward in building the health AI operating system of the future, using language models to consolidate various point solutions into a single, integrated platform for providers, clinical operations teams, and healthcare IT.”

The acquisition of Augmedix by Commure marks a significant development in the healthcare technology sector, with the combined expertise and resources of both companies poised to drive innovation and efficiency in medical documentation and data solutions. The move is expected to strengthen Commure’s market position and enable the company to capitalize on new opportunities in the rapidly evolving healthcare landscape.